U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Azacitidine Injection
Status: Currently in Shortage
»Date first posted: 12/18/2020
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Reverified 10/03/2026)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azacitidine, Injection, 100 mg (NDC 16729-306-10) Available

Armas Pharmaceuticals Inc (Revised 06/08/2026)

Company Contact Information:
732-637-1971

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azacitidine, Injection, 100 mg (NDC 72485-201-01) Limited Availability Estimated recovery: TBD Other

Bristol Myers Squibb Co. (Reverified 10/15/2026)

Company Contact Information:
1-888-423-5436

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Vidaza, Injection, 100 mg (NDC 59572-102-01) Available

Dr. Reddy's Laboratories, Inc. (Reverified 09/29/2026)

Company Contact Information:
866-732-3952

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azacitidine, Injection, 100 mg (NDC 43598-305-62) Available Available to existing customers

Eugia US LLC (Reverified 10/02/2026)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) Unavailable On backorder. Recovery: TBD. Check wholesalers for inventory Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 10/15/2026)

Company Contact Information:
1-888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug

Hikma Pharmaceuticals USA, Inc. (Reverified 09/18/2026)

Company Contact Information:
1-800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released.

Meitheal Pharmaceuticals, Inc. (Reverified 08/27/2026)

Company Contact Information:
844-824-8426

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) Available

Teva Pharmaceuticals USA, Inc. (Reverified 10/15/2026)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Azacitidine, Injection, 100 mg (NDC 68001-313-56) Unavailable Estimated recovery: TBD Other
Back to Top